Recurrent glioma clinical trial, CheckMate-143: the game is not over yetAnna C. Filley(Indiana University – Purdue University Indianapolis), Mahua Dey(Indiana University – Purdue University Indianapolis)OncotargetOctober 6, 201710.18632/oncotarget.21586Cited by 418SaveCiteExport RISWatch citationsRelated PapersCommon Molecular Alterations in Canine Oligodendroglioma and Human Malignant Gliomas and Potential Novel Therapeutic Targets|Frontiers in Oncology|2019|14